Medichem
Medichem, officially known as Medichem S.A., is a leading player in the pharmaceutical industry, headquartered in Spain (ES). Established in 1985, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates, serving a global clientele across Europe, Asia, and the Americas. With a strong focus on quality and innovation, Medichem offers a diverse range of products, including complex APIs for various therapeutic areas. Their commitment to sustainability and regulatory compliance sets them apart in a competitive market. Notably, Medichem has achieved several certifications, reinforcing its position as a trusted partner in the pharmaceutical supply chain. As a pioneer in the industry, Medichem continues to drive advancements in pharmaceutical manufacturing, ensuring high standards and reliability for its customers.
DitchCarbon Score
How does Medichem's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medichem's score of 24 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medichem's reported carbon emissions
In 2023, Medichem reported total carbon emissions of approximately 42,401,000 kg CO2e, comprising 1,235,000 kg CO2e from Scope 1, 1,803,000 kg CO2e from Scope 2 (market-based), and a significant 39,363,000 kg CO2e from Scope 3 emissions. This reflects a decrease from 2022, where total emissions were about 54,088,000 kg CO2e, indicating a positive trend in their climate impact. In 2021, Medichem's emissions in Spain were approximately 2,209,000 kg CO2e for Scope 1 and Scope 2 combined, with 1,185,000 kg CO2e from Scope 1 and 1,024,000 kg CO2e from Scope 2 (market-based). Despite these figures, Medichem has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company is positioned within an industry increasingly focused on sustainability, and its emissions data highlights the need for ongoing efforts to mitigate climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,938,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,943,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medichem is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
